Cite
Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease
MLA
Emily Taillieu, et al. “Clinical Significance and Impact of Gastric Non-Helicobacter Pylori Helicobacter Species in Gastric Disease.” Alimentary Pharmacology and Therapeutics, Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4bddfbeff8ee5909f7b44498a98cdc98&authtype=sso&custid=ns315887.
APA
Emily Taillieu, Chloë De Witte, Heiko De Schepper, Wouter Van Moerkercke, Sophie Rutten, Stijn Michiels, Yuna Arnst, Sofie De Bruyckere, Sven Francque, Frauke van Aert, Christophe George, Emma Callewaert, Tiene Callewaert, Glenn Vanneste, Erik Vanderstraeten, Nina Van Heddegem, Margaux Vansteelant, Koen Chiers, Freddy Haesebrouck, & Christophe Van Steenkiste. (2023). Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease. Alimentary Pharmacology and Therapeutics.
Chicago
Emily Taillieu, Chloë De Witte, Heiko De Schepper, Wouter Van Moerkercke, Sophie Rutten, Stijn Michiels, Yuna Arnst, et al. 2023. “Clinical Significance and Impact of Gastric Non-Helicobacter Pylori Helicobacter Species in Gastric Disease.” Alimentary Pharmacology and Therapeutics, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4bddfbeff8ee5909f7b44498a98cdc98&authtype=sso&custid=ns315887.